Faculty | UCLA Saphir

Raphael Landovitz, MD, MSc

Raphael Landovitz, MD, MSc (Biomedical HIV Prevention) is Assistant Professor of Medicine in the Department of Medicine, Division of Infectious Diseases. Dr. Landovitz’s research focuses on pre- and post-exposure antiretroviral prophylaxis and other biomedical strategies to prevent HIV infection in methamphetamine users and other high-risk populations, and the use of novel technologies for epidemiologic assessment, HIV prevention messaging, and study recruitment.

Research Interests:

Pre-exposure Prophylaxis

Post Exposure Prophylaxis

HIV Treatment as Prevention

Selected Recent Publications:

Landovitz RJ, Fletcher JB, Shoptaw S, Reback CJ. Contingency Management facilitates the use of Post-Exposure Prophylaxis among Stimulant-using Men who have Sex with Men. Open Forum Infectious Diseases. 2015.

Lennox JL, Landovitz RJ, Ribaudo HJ, et al. Efficacy and Tolerability of 3 Nonnucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naive Volunteers Infected With HIV-1: A Randomized, Controlled Equivalence Trial. Ann Intern Med. 2014 Oct 7;161(7):461-71

Beymer MR, Bolan RK, Flynn RP, Kerrone DR, Pieribone DL,Kulkarni SP, Stitt JC, Mejia E, Landovitz RJ. Uptake and repeat use of post-exposure prophylaxis in a community-based clinic in Los Angeles, California. AIDS Res Hum Retroviruses. 2014 Sep;30(9):848-55.

Landovitz RJ, Fletcher JB, Shoptaw S, Reback CJ. A Novel Combination HIV Prevention Strategy: Post-Exposure Prophylaxis with Contingency Management for Substance Abuse Treatment among Methamphetamine-using Men who have Sex with Men. AIDS Patient Care STDS. 2012 Jun;26(6):320-8.